Switch theme
Sign up to access all valuation multiples
Bangkok Dusit Medical Services PCL operates a network of hospitals throughout Thailand under the Bangkok Hospital, Phyathai Hospital, Samitivej Hospital, Paolo Hospital, BNH Hospital, and Royal International Hospital brands. The company has two business segments namely, hospital operations and other businesses that support hospital business such as medical laboratories, production and distribution of pharmaceutical products/medical equipment/saline, pharmacies, assets management for healthcare business, accounting services, technology and information services, training business and insurance broker. The company's hospital operations generate the vast majority of its revenue.
1969
56.0K+
LTM Revenue $3.3B
LTM EBITDA $812M
$10.6B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Bangkok Dusit Medical Services has a last 12-month revenue (LTM) of $3.3B and a last 12-month EBITDA of $812M.
In the most recent fiscal year, Bangkok Dusit Medical Services achieved revenue of $3.3B and an EBITDA of $820M.
Bangkok Dusit Medical Services expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Bangkok Dusit Medical Services valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $3.3B | XXX | $3.3B | XXX | XXX | XXX |
| Gross Profit | $1.2B | XXX | $1.2B | XXX | XXX | XXX |
| Gross Margin | 35% | XXX | 37% | XXX | XXX | XXX |
| EBITDA | $812M | XXX | $820M | XXX | XXX | XXX |
| EBITDA Margin | 24% | XXX | 25% | XXX | XXX | XXX |
| EBIT | $616M | XXX | $623M | XXX | XXX | XXX |
| EBIT Margin | 18% | XXX | 19% | XXX | XXX | XXX |
| Net Profit | $501M | XXX | $487M | XXX | XXX | XXX |
| Net Margin | 15% | XXX | 15% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $95.3M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Bangkok Dusit Medical Services's stock price is THB 22 (or $1).
Bangkok Dusit Medical Services has current market cap of THB 343B (or $10.5B), and EV of THB 349B (or $10.6B).
See Bangkok Dusit Medical Services trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $10.6B | $10.5B | XXX | XXX | XXX | XXX | $0.03 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Bangkok Dusit Medical Services has market cap of $10.5B and EV of $10.6B.
Bangkok Dusit Medical Services's trades at 3.2x EV/Revenue multiple, and 13.0x EV/EBITDA.
Equity research analysts estimate Bangkok Dusit Medical Services's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Bangkok Dusit Medical Services has a P/E ratio of 20.9x.
See valuation multiples for Bangkok Dusit Medical Services and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $10.5B | XXX | $10.5B | XXX | XXX | XXX |
| EV (current) | $10.6B | XXX | $10.6B | XXX | XXX | XXX |
| EV/Revenue | 3.2x | XXX | 3.2x | XXX | XXX | XXX |
| EV/EBITDA | 13.1x | XXX | 13.0x | XXX | XXX | XXX |
| EV/EBIT | 17.2x | XXX | 17.0x | XXX | XXX | XXX |
| EV/Gross Profit | 9.1x | XXX | n/a | XXX | XXX | XXX |
| P/E | 20.9x | XXX | 21.5x | XXX | XXX | XXX |
| EV/FCF | 27.7x | XXX | 30.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialBangkok Dusit Medical Services's last 12 month revenue growth is 6%
Bangkok Dusit Medical Services's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $11K for the same period.
Bangkok Dusit Medical Services's rule of 40 is 31% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Bangkok Dusit Medical Services's rule of X is 40% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Bangkok Dusit Medical Services and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 6% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Margin | 24% | XXX | 25% | XXX | XXX | XXX |
| EBITDA Growth | 6% | XXX | 5% | XXX | XXX | XXX |
| Rule of 40 | 31% | XXX | 31% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 40% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $11K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 18% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Burjeel Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Athens Medical Centre | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Bangkok Dusit Medical Services acquired XXX companies to date.
Last acquisition by Bangkok Dusit Medical Services was XXXXXXXX, XXXXX XXXXX XXXXXX . Bangkok Dusit Medical Services acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Bangkok Dusit Medical Services founded? | Bangkok Dusit Medical Services was founded in 1969. |
| Where is Bangkok Dusit Medical Services headquartered? | Bangkok Dusit Medical Services is headquartered in Thailand. |
| How many employees does Bangkok Dusit Medical Services have? | As of today, Bangkok Dusit Medical Services has 56.0K+ employees. |
| Who is the CEO of Bangkok Dusit Medical Services? | Bangkok Dusit Medical Services's CEO is Dr. Poramaporn Prasarttong-Osoth, M.D.. |
| Is Bangkok Dusit Medical Services publicy listed? | Yes, Bangkok Dusit Medical Services is a public company listed on BKK. |
| What is the stock symbol of Bangkok Dusit Medical Services? | Bangkok Dusit Medical Services trades under BDMS ticker. |
| When did Bangkok Dusit Medical Services go public? | Bangkok Dusit Medical Services went public in 1991. |
| Who are competitors of Bangkok Dusit Medical Services? | Similar companies to Bangkok Dusit Medical Services include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health. |
| What is the current market cap of Bangkok Dusit Medical Services? | Bangkok Dusit Medical Services's current market cap is $10.5B |
| What is the current revenue of Bangkok Dusit Medical Services? | Bangkok Dusit Medical Services's last 12 months revenue is $3.3B. |
| What is the current revenue growth of Bangkok Dusit Medical Services? | Bangkok Dusit Medical Services revenue growth (NTM/LTM) is 6%. |
| What is the current EV/Revenue multiple of Bangkok Dusit Medical Services? | Current revenue multiple of Bangkok Dusit Medical Services is 3.2x. |
| Is Bangkok Dusit Medical Services profitable? | Yes, Bangkok Dusit Medical Services is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Bangkok Dusit Medical Services? | Bangkok Dusit Medical Services's last 12 months EBITDA is $812M. |
| What is Bangkok Dusit Medical Services's EBITDA margin? | Bangkok Dusit Medical Services's last 12 months EBITDA margin is 24%. |
| What is the current EV/EBITDA multiple of Bangkok Dusit Medical Services? | Current EBITDA multiple of Bangkok Dusit Medical Services is 13.1x. |
| What is the current FCF of Bangkok Dusit Medical Services? | Bangkok Dusit Medical Services's last 12 months FCF is $383M. |
| What is Bangkok Dusit Medical Services's FCF margin? | Bangkok Dusit Medical Services's last 12 months FCF margin is 11%. |
| What is the current EV/FCF multiple of Bangkok Dusit Medical Services? | Current FCF multiple of Bangkok Dusit Medical Services is 27.7x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
